ANIP logo

ANI Pharmaceuticals (ANIP) Long Term Debt

Annual Long Term Debt

$284.82 M
-$850.00 K-0.30%

31 December 2023

ANIP Long Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Debt

$618.21 M
+$333.82 M+117.38%

30 September 2024

ANIP Quarterly Long Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ANIP Long Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-0.3%+116.9%
3 y3 years+65.2%+232.3%
5 y5 years+323.2%+853.0%

ANIP Long Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-0.6%+65.2%at high+232.3%
5 y5 years-0.6%+323.2%at high+853.0%
alltimeall time-0.6%+1607.9%at high+5791.3%

ANI Pharmaceuticals Long Term Debt History

DateAnnualQuarterly
Sept 2024
-
$618.21 M(+117.4%)
June 2024
-
$284.39 M(-0.1%)
Mar 2024
-
$284.61 M(-0.1%)
Dec 2023
$284.82 M(-0.3%)
$284.82 M(-0.1%)
Sept 2023
-
$285.03 M(-0.1%)
June 2023
-
$285.24 M(-0.1%)
Mar 2023
-
$285.46 M(-0.1%)
Dec 2022
$285.67 M(-0.3%)
$285.67 M(-0.1%)
Sept 2022
-
$285.88 M(-0.1%)
June 2022
-
$286.10 M(-0.1%)
Mar 2022
-
$286.31 M(-0.1%)
Dec 2021
$286.52 M(+66.2%)
$286.52 M(+54.0%)
Sept 2021
-
$186.06 M(-1.8%)
June 2021
-
$189.53 M(+12.2%)
Mar 2021
-
$168.99 M(-2.0%)
Dec 2020
$172.44 M(-1.9%)
$172.44 M(-1.6%)
Sept 2020
-
$175.16 M(-1.5%)
June 2020
-
$177.88 M(-5.4%)
Mar 2020
-
$188.09 M(+7.0%)
Dec 2019
$175.81 M(+161.2%)
$175.81 M(+171.0%)
Sept 2019
-
$64.87 M(-1.2%)
June 2019
-
$65.69 M(-1.2%)
Mar 2019
-
$66.50 M(-1.2%)
Dec 2018
$67.30 M
$67.30 M(-66.4%)
Sept 2018
-
$200.08 M(+0.3%)
DateAnnualQuarterly
June 2018
-
$199.39 M(+0.3%)
Mar 2018
-
$198.72 M(+0.3%)
Dec 2017
$198.15 M(+64.2%)
$198.15 M(+31.0%)
Sept 2017
-
$151.28 M(-2.0%)
June 2017
-
$154.38 M(+1.2%)
Mar 2017
-
$152.50 M(+26.4%)
Dec 2016
$120.64 M(+6.4%)
$120.64 M(+1.5%)
Sept 2016
-
$118.81 M(+1.6%)
June 2016
-
$116.99 M(+1.6%)
Mar 2016
-
$115.20 M(+1.6%)
Dec 2015
$113.43 M(+6.5%)
$113.43 M(-1.5%)
Sept 2015
-
$115.19 M(+1.3%)
June 2015
-
$113.67 M(+1.3%)
Mar 2015
-
$112.17 M(+5.3%)
Dec 2014
$106.54 M(+514.5%)
$106.54 M(+915.3%)
Mar 2012
-
$10.49 M(-39.5%)
Dec 2011
$17.34 M(-0.6%)
$17.34 M(-9.9%)
Sept 2011
-
$19.24 M(-2.6%)
June 2011
-
$19.75 M(+9.5%)
Mar 2011
-
$18.04 M(+3.4%)
Dec 2010
$17.44 M(+4.6%)
$17.44 M(-5.1%)
Sept 2010
-
$18.36 M(-0.6%)
June 2010
-
$18.47 M(+2.1%)
Mar 2010
-
$18.09 M(+8.4%)
Dec 2009
$16.68 M
$16.68 M

FAQ

  • What is ANI Pharmaceuticals annual long term debt?
  • What is the all time high annual long term debt for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals annual long term debt year-on-year change?
  • What is ANI Pharmaceuticals quarterly long term debt?
  • What is the all time high quarterly long term debt for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals quarterly long term debt year-on-year change?

What is ANI Pharmaceuticals annual long term debt?

The current annual long term debt of ANIP is $284.82 M

What is the all time high annual long term debt for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high annual long term debt is $286.52 M

What is ANI Pharmaceuticals annual long term debt year-on-year change?

Over the past year, ANIP annual long term debt has changed by -$850.00 K (-0.30%)

What is ANI Pharmaceuticals quarterly long term debt?

The current quarterly long term debt of ANIP is $618.21 M

What is the all time high quarterly long term debt for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high quarterly long term debt is $618.21 M

What is ANI Pharmaceuticals quarterly long term debt year-on-year change?

Over the past year, ANIP quarterly long term debt has changed by +$333.18 M (+116.89%)